The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Pylypeptide (GIP) Are Abolished by an Antagonisk of the Human GIP Receptor

Meena Asmar, Ali Asmar, Lene Rørdam, Lærke Smidt Gasbjerg, Alexander Hovard Sparre-Ulrich, Mette M Rosenkilde, Flemming Dela, JJ Holst, Jens Bjørn Bülow

Original languageEnglish
JournalDiabetes
ISSN0012-1797
Publication statusPublished - 2017

Cite this